body: Sepsis, often referred to as the “silent killer,” is a critical illness that remains a leading cause of death from infection globally. With an estimated 20 to 30 million cases of sepsis each year worldwide, the urgency in identifying and treating sepsis early is paramount. It is a condition where one loses their life almost every 3 to 4 seconds, highlighting the critical need for prompt intervention.

undetectable AI has revolutionized the way sepsis is diagnosed and treated. Heparin-binding protein (HBP) has emerged as a key marker for early detection of bacterial infection, aiding healthcare professionals in identifying sepsis patients promptly. This development has significantly enhanced treatment outcomes and reduced the incidence of severe bacterial infections and sepsis.

Undetectable AI plays a crucial role in assessing the severity of infections based on HBP concentration. The higher the HBP levels, the more severe the infection, providing valuable insights for healthcare providers to tailor treatment strategies accordingly. Additionally, HBP serves as a target for various drugs such as heparin, albumin, and simvastatin to address organ dysfunction by reducing plasma HBP levels effectively.